Drawing for PROFUNDUS

USPTO serial 79381845

PROFUNDUS

Reviewed by CopyMark Law Group

Reg. 7546902Status 700Registered
Filing date
Status date
Registration date
Oct 29, 2024
Examiner
AREY, BRANDON LEON
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PROFUNDUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leigh Ann Lindquist

Leigh Ann Lindquist Sughrue Mion, PLLC2000 Pennsylvania Ave. N.W., Suite 9000Washington, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded software for medical retinal imaging; Internet cloud servers for archiving and viewing digital images; cameras; optical apparatus and instruments, namely retina cameras, fundus cameras and adaptive optics retina camera; computer hardware and downloadable and/or recorded software for processing and displaying retina images, controlling and managing patient information, for interpreting results of retinal imaging apparatus, in the field of eye health diagnosticsACTIVE—
010Medical apparatus and instruments, namely retinal imaging apparatus; retinal imaging instruments for medical purposes; ophthalmic cameras for medical purposes; retinal imaging systems having a confocal base and cameras for detecting, managing and diagnosing retinal pathologies and glaucoma; medical instrument, namely retinal imaging apparatus for use in the field of ophthalmologyACTIVE—
041Educational services, namely providing classes, online classes and seminars in fields of eye medicine, eye diagnostics, ophthalmology, optometry and photometryACTIVE—
042Scientific and industrial research in the field of retinal imaging, ophthalmology; computer programming; software as a service (saas) featuring computer software for enabling retinal photography, storing retina images, analysing and quantifying images, providing data on the retinal health, support with eye health diagnostics; design and development of computer hardware and software, all the aforesaid services in the fields of eye diagnostics, ophthalmology, optometry and photometry, for research, for clinical workACTIVE—
045Licensing of technology, namely the licensing of systems, or parts thereof, relating to ophthalmology, optometry and/or photometry for eye health diagnosticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 4, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 19, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 12, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 2, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 2, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 25, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 25, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 29, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 29, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 29, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 13, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 13, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 9, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 9, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 9, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 9, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2024RFNTREFUSAL PROCESSED BY IB—
May 2, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 1, 2024RFRRREFUSAL PROCESSED BY MPU—
Apr 25, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 24, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2024DOCKASSIGNED TO EXAMINER—
Nov 11, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 7, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 26, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance